Welcome to the iCAD Investors Page

iCAD, Inc. an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The core business delivers innovative cancer detection and radiation therapy  solutions and services that enable clinicians to find and treat cancers earlier and  while enhancing patient care. The comprehensive iCAD technology platforms include advanced hardware and software as well as management services designed to support cancer detection (CAD) and radiation therapy (eBx) treatments.

The company's common stock is listed on the NASDAQ Stock Market under the symbol "ICAD".

Featured Financial Press Releases

2016  |  2015  |  2014  |  2013  |  2012  |  2011  |  2010  |  2009

November 30, 2016
iCAD To Present At The 9th Annual LD Micro Main Event
Read More

November 10, 2016
iCAD To Present At Two Investor Conferences In November 2016
Read More

November 8, 2016
iCAD Appoints Richard Christopher Executive Vice President and Chief Financial Officer
Read More

November 2, 2016
iCAD Reports Third Quarter 2016 Financial Results
Read More

* See all Financial Press Releases

Investor Relations

The Ruth Group

Zack Kubow,
646-536-7020

iCAD@theruthgroup.com

Media Inquiries

Berry & Company Public Relations, LLC

Lynn Granito

+1 212-253-8881

icad@berrypr.com

CAD is committed to corporate sustainability and to making a difference for our environment.

iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and while enhancing patient care. iCAD offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast, prostate and colorectal cancers.

Facebook Twitter LinkedIn

© 2017, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo and Never Stop Looking is a trademark of iCAD, Inc.

Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.